Principal PKPD Scientist
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Måløv
. Are you a scientist with flair for mathematical modelling and knowledge of pharmacology, biology or physiology? Are you passionate about PKPD and model-based drug development for linking the preclinical space to the clinic? If you're ready to drive innovation and make a meaningful impact in the field of PKPD, we have an exciting opportunity waiting for you! Come and join our Development PKPD department. The position
As a Principal Development PKPD Scientist, you will be involved in a great variety of tasks related to PK and PKPD assessment, modelling and translation. You will be supporting interdisciplinary project teams across the value chain from early non-clinical development to submission. You will join a dynamic team that fosters knowledge-sharing, collaboration and a supportive environment where individuals contribute with their expertise and collectively drives the implementation of mathematical modelling across the value chain. Your key stakeholders will include preclinical and clinical scientists across various scientific areas, as well as Development and Non-clinical project teams. You will also interact with scientists using machine learning, data science and human centric in vitro methods.
Some of your main responsibilities will include: Setting the direction and drive the execution of the translational PK and PK/PD strategy across modalities and in alignment with key stakeholders to ensure efficient project progression Designing preclinical PK and PK/PD studies, collecting and reporting data Building mathematical models and performing simulations of human PK and PD based on in vitro and animal data as well as literature data on relevant compounds Informing and guiding projects within topics related to e.g. preclinical study designs, toxicity studies dose setting as well as first in human clinical dose setting and trial design Interacting with regulatory authorities, including providing written input to regulatory documents (e.g. IND, IMPD, NDA) Demonstrating ability to drive and maintain state of the art competencies and know-how within PK/PD, as well as being an innovator impacting the R&D value chain Independently solving unique and complex problems that have a broad impact on the business Qualifications To succeed in the role, we expect you to have: Ph.D. within Pharmaceuticals, Medical, Physics, Math or Engineering sciences, or other disciplines or equivalent pharmaceutical industry experience and ideally have several years of relevant experience (post PhD) within the pharmaceutical/biotech industry Strong understanding of PK/PD theory, modelling methodology, data interpretation and translational science methodologies Outstanding ability to identify challenges, develop strategies, and translate them into actionable work packages Solid experience with and understanding of pharmacokinetics and modelling software (e.g. Phoenix WinNonlin/NLME, NONMEM or equivalent), as well as software for data processing and analysis (e.g. R, Python, Matlab) General digital literacy across generative AI platforms such as ChatGPT and CoPilot is preferred Experience in managing external service providers is an advantage Experience with Due diligence evaluation within PBPK and PKPD is an advantage On a personal level, you have exceptional communication and stakeholder management skills and the ability to effectively interact with colleagues with a variety of backgrounds. You work effectively within cross-functional teams and with external partners to drive research initiatives and achieve project goals.
All candidates with relevant qualifications interested in the role are encouraged to apply. Your application might be considered for a different level of the same position. About the department
In Development PKPD you will have dedicated and highly motivated colleagues supporting projects with pharmacokinetic and pharmacodynamic evaluation using a variety of modelling and simulation tools from early non-clinical development to submission. Our evaluation is essential to secure project progress.
In preclinical development we are responsible for predicting human PK and PK/PD, setting doses for preclinical studies and for first in human trials, and reporting toxicokinetics to GLP, as well as providing input to regulatory documents (e.g. IND, IMPD, NDA). During clinical development, we conduct the interim PK evaluation during early phase 1 trials and collaborate with clinical pharmacologists and clinical pharmacometrics to support later clinical pharmacology studies (e.g. Drug-Drug-Interaction, renal and hepatic impairment) as well as addressing PBPK and PK/PD related questions and issues as they may arise. The models inform and support drug discovery, development and regulatory interactions.
The department is anchored within Global Drug Discovery (GDD) in Research & Early Development (R&ED) and in our daily work, we have a close collaboration with all parts of the global Discovery and Development organization, global project teams as well as external collaborators. Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care. Contact
For further information please contact Line Hollesen Schefe, Manager Development PKPD on +45-3077 6009. Deadline
1 September 2024. Applications will be assessed on an ongoing basis and we might call in for interviews before the application deadline. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
As a Principal Development PKPD Scientist, you will be involved in a great variety of tasks related to PK and PKPD assessment, modelling and translation. You will be supporting interdisciplinary project teams across the value chain from early non-clinical development to submission. You will join a dynamic team that fosters knowledge-sharing, collaboration and a supportive environment where individuals contribute with their expertise and collectively drives the implementation of mathematical modelling across the value chain. Your key stakeholders will include preclinical and clinical scientists across various scientific areas, as well as Development and Non-clinical project teams. You will also interact with scientists using machine learning, data science and human centric in vitro methods.
Some of your main responsibilities will include:
All candidates with relevant qualifications interested in the role are encouraged to apply. Your application might be considered for a different level of the same position. About the department
In Development PKPD you will have dedicated and highly motivated colleagues supporting projects with pharmacokinetic and pharmacodynamic evaluation using a variety of modelling and simulation tools from early non-clinical development to submission. Our evaluation is essential to secure project progress.
In preclinical development we are responsible for predicting human PK and PK/PD, setting doses for preclinical studies and for first in human trials, and reporting toxicokinetics to GLP, as well as providing input to regulatory documents (e.g. IND, IMPD, NDA). During clinical development, we conduct the interim PK evaluation during early phase 1 trials and collaborate with clinical pharmacologists and clinical pharmacometrics to support later clinical pharmacology studies (e.g. Drug-Drug-Interaction, renal and hepatic impairment) as well as addressing PBPK and PK/PD related questions and issues as they may arise. The models inform and support drug discovery, development and regulatory interactions.
The department is anchored within Global Drug Discovery (GDD) in Research & Early Development (R&ED) and in our daily work, we have a close collaboration with all parts of the global Discovery and Development organization, global project teams as well as external collaborators. Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care. Contact
For further information please contact Line Hollesen Schefe, Manager Development PKPD on +45-3077 6009. Deadline
1 September 2024. Applications will be assessed on an ongoing basis and we might call in for interviews before the application deadline. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Måløv.
Jobbet er oprettet på vores service den 1.8.2024, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Måløv
Lignende jobs
-
Strategic Trial Planning Manager - Clinical Develo...
Are you ready to drive the successful strategic planning and management of early phase clinical trials, i.e. ClinPharm/Phase 1 studies? Does oversight and cross functional collaboration motivate yo..- Forretningsudvikler
- Søborg
-
Senior Scientist in Late-stage Downstream Developm...
Are you ready to shape the future of API process characterization in late-stage downstream development? Do you have the expertise to drive innovative solutions and ensure seamless tech transfer in .- Forretningsudvikler
- Bagsværd
-
Global Trial Manager
Are you passionate about clinical development? Is ensuring that clinical trials produce high-quality data and scientific documentation your top priority? If so, we want you to join our team in Card..- Forretningsudvikler
- Søborg
-
Udviklingskonsulent til det sociale børne- og unge...
- Forretningsudvikler
- Taastrup
Statistik over udbudte jobs som forretningsudviklere i Måløv
Herunder ser du udviklingen i udbudte forretningsudvikler i Måløv over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Måløv over tid
Dato | Alle jobs som forretningsudviklere |
---|---|
22. november 2024 | 3 |
21. november 2024 | 3 |
20. november 2024 | 4 |
19. november 2024 | 3 |
18. november 2024 | 3 |
17. november 2024 | 5 |
16. november 2024 | 5 |
15. november 2024 | 5 |
14. november 2024 | 5 |
13. november 2024 | 5 |
12. november 2024 | 5 |
11. november 2024 | 4 |
10. november 2024 | 4 |
9. november 2024 | 4 |
8. november 2024 | 3 |
7. november 2024 | 2 |
6. november 2024 | 1 |
5. november 2024 | 1 |
4. november 2024 | 1 |
3. november 2024 | 3 |
2. november 2024 | 3 |
1. november 2024 | 3 |
31. oktober 2024 | 4 |
30. oktober 2024 | 4 |
29. oktober 2024 | 4 |
28. oktober 2024 | 4 |
27. oktober 2024 | 6 |
26. oktober 2024 | 6 |
25. oktober 2024 | 7 |
24. oktober 2024 | 7 |
23. oktober 2024 | 7 |